Tenecteplase
TNKase, Metalyse (tenecteplase) is an enzyme pharmaceutical. Tenecteplase was first approved as TNKase on 2000-06-02. It is used to treat coronary thrombosis and myocardial infarction in the USA. It has been approved in Europe to treat myocardial infarction.
| Trade Name | Metalyse |
|---|---|
| Common Name | Tenecteplase |
| Indication | coronary thrombosis, myocardial infarction |
| Drug Class | Enzymes: tissue-type plasminogen activators |
